ARCT
Price
$17.85
Change
+$1.09 (+6.50%)
Updated
Sep 5 closing price
Capitalization
484.71M
59 days until earnings call
AXON
Price
$728.41
Change
-$1.75 (-0.24%)
Updated
Sep 5 closing price
Capitalization
57.18B
60 days until earnings call
Interact to see
Advertisement

ARCT vs AXON

Header iconARCT vs AXON Comparison
Open Charts ARCT vs AXONBanner chart's image
Arcturus Therapeutics Holdings
Price$17.85
Change+$1.09 (+6.50%)
Volume$511.46K
Capitalization484.71M
Axon Enterprise
Price$728.41
Change-$1.75 (-0.24%)
Volume$398.3K
Capitalization57.18B
ARCT vs AXON Comparison Chart in %
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. AXON commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a StrongBuy and AXON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ARCT: $17.85 vs. AXON: $728.41)
Brand notoriety: ARCT and AXON are both not notable
ARCT represents the Biotechnology, while AXON is part of the Aerospace & Defense industry
Current volume relative to the 65-day Moving Average: ARCT: 93% vs. AXON: 63%
Market capitalization -- ARCT: $484.71M vs. AXON: $57.18B
ARCT [@Biotechnology] is valued at $484.71M. AXON’s [@Aerospace & Defense] market capitalization is $57.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $296.11B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B. The average market capitalization across the [@Aerospace & Defense] industry is $21.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileAXON’s FA Score has 2 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • AXON’s FA Score: 2 green, 3 red.
According to our system of comparison, AXON is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 6 TA indicator(s) are bullish while AXON’s TA Score has 3 bullish TA indicator(s).

  • ARCT’s TA Score: 6 bullish, 4 bearish.
  • AXON’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than AXON.

Price Growth

ARCT (@Biotechnology) experienced а +4.94% price change this week, while AXON (@Aerospace & Defense) price change was -2.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -0.14%. For the same industry, the average monthly price growth was +0.05%, and the average quarterly price growth was +41.74%.

Reported Earning Dates

ARCT is expected to report earnings on Nov 05, 2025.

AXON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Aerospace & Defense (-0.14% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($57.2B) has a higher market cap than ARCT($485M). AXON YTD gains are higher at: 22.562 vs. ARCT (5.186). AXON has higher annual earnings (EBITDA): 341M vs. ARCT (-54.54M). AXON has more cash in the bank: 2.23B vs. ARCT (196M). ARCT has less debt than AXON: ARCT (27M) vs AXON (2.05B). AXON has higher revenues than ARCT: AXON (2.39B) vs ARCT (110M).
ARCTAXONARCT / AXON
Capitalization485M57.2B1%
EBITDA-54.54M341M-16%
Gain YTD5.18622.56223%
P/E RatioN/A179.41-
Revenue110M2.39B5%
Total Cash196M2.23B9%
Total Debt27M2.05B1%
FUNDAMENTALS RATINGS
ARCT vs AXON: Fundamental Ratings
ARCT
AXON
OUTLOOK RATING
1..100
9163
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
1009
SMR RATING
1..100
9656
PRICE GROWTH RATING
1..100
3847
P/E GROWTH RATING
1..100
10010
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARCT's Valuation (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for AXON (90) in the Biotechnology industry. This means that ARCT’s stock grew somewhat faster than AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (9) in the Biotechnology industry is significantly better than the same rating for ARCT (100) in the Pharmaceuticals Major industry. This means that AXON’s stock grew significantly faster than ARCT’s over the last 12 months.

AXON's SMR Rating (56) in the Biotechnology industry is somewhat better than the same rating for ARCT (96) in the Pharmaceuticals Major industry. This means that AXON’s stock grew somewhat faster than ARCT’s over the last 12 months.

ARCT's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as AXON (47) in the Biotechnology industry. This means that ARCT’s stock grew similarly to AXON’s over the last 12 months.

AXON's P/E Growth Rating (10) in the Biotechnology industry is significantly better than the same rating for ARCT (100) in the Pharmaceuticals Major industry. This means that AXON’s stock grew significantly faster than ARCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARCTAXON
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 5 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BABX33.622.18
+6.93%
GraniteShares 2x Long BABA Daily ETF
EWY73.630.56
+0.77%
iShares MSCI South Korea ETF
IBDZ26.500.20
+0.76%
iShares iBonds Dec 2034 Term Corp ETF
ISCV67.550.36
+0.53%
iShares Morningstar Small-Cap Value ETF
JPSV60.370.04
+0.07%
JPMorgan Active Small Cap Value ETF

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with RGNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+6.50%
RGNX - ARCT
51%
Loosely correlated
+3.08%
CLDX - ARCT
50%
Loosely correlated
+0.40%
AXON - ARCT
49%
Loosely correlated
-0.24%
MRNA - ARCT
46%
Loosely correlated
+3.54%
MGNX - ARCT
46%
Loosely correlated
+3.09%
More